Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | ELANE | P08246 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.37 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22685742 | 1.00 | L3MBTL1 (0.46) | L3MBTL1KDM4ESMN1; SMN2TSHRGAA | |
| SCHEMBL24448 | 0.98 | — | — | |
| SCHEMBL29391736 | 0.98 | — | — | |
| Propane SCHEMBL28751201 | 0.95 | L3MBTL1 (0.46) | L3MBTL1KDM4ESMN1; SMN2TSHRGAA | |
| Hydrochloric Acid SCHEMBL29018520 | 0.95 | L3MBTL1 (0.46) | L3MBTL1KDM4ESMN1; SMN2TSHRGAA | |
| SCHEMBL29361262 | 0.95 | L3MBTL1 (0.46) | L3MBTL1KDM4ESMN1; SMN2TSHRGAA | |
| Hydrochloric Acid SCHEMBL11591675 | 0.95 | L3MBTL1 (0.46) | L3MBTL1KDM4ESMN1; SMN2TSHRGAA | |
| Water SCHEMBL29067376 | 0.95 | L3MBTL1 (0.46) | L3MBTL1KDM4ESMN1; SMN2TSHRGAA | |
| SCHEMBL16594911 | 0.89 | SMN1; SMN2 (0.44) | L3MBTL1KDM4ESMN1; SMN2TSHRGAA | |
| SCHEMBL3893320 | 0.84 | CYP11B1 (0.42) | L3MBTL1KDM4ESMN1; SMN2TSHRGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 580 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113874355-B | Process for the manufacture of (6 AR,10 AR) -7-propyl-6, 6A,7,8,9, 10A, 11-octahydro- [1,3] dioxolo [4',5':5,6] benzo [1,2-G ] quinoline and (4 AR,10 AR) -1-propyl-1, 2,3, 4A,5, 10A-octahydro-benzo [ G ] quinoline-6, 7-diol | H.隆德贝克有限公司 | 2024-07-30 | — | — | CN | claimed |
| US-20240018107-A1 | PROCESS FOR THE MANUFACTURING OF (6AR,10AR)-7-PROPYL-6,6A,7,8,9,10,10A,11-OCTAHYDRO-[1,3]DIOXOLO[4',5':5,6]BENZO[1,2-G]QUINOLINE AND (4AR,10AR)-1-PROPYL-1,2,3,4,4A,5,10,10A-OCTAHYDRO-BENZO[G]QUINOLINE-6,7-DIOL | H. LUNDBECK A/S (DK) | 2024-01-18 | — | — | US | claimed |
| US-20230346903-A1 | GROUP B STREPTOCOCCUS POLYSACCHARIDE-PROTEIN CONJUGATES, METHODS FOR PRODUCING CONJUGATES, IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATES, AND USES THEREOF | PFIZER INC. (US) | 2023-11-02 | — | — | US | claimed |
| WO-2023118207-A1 | PROCESS FOR DYEING A CELLULOSIC MATERIAL | PILI (FR) | 2023-06-29 | — | — | WO | claimed |
| CN-114195902-B | Recombinant protein structural domain enhanced TET enzyme and whole genome DNA methylation detection method | 翌圣生物科技(上海)股份有限公司 | 2023-06-20 | — | — | CN | claimed |
| CN-114591439-B | Recombinant TET enzyme MBD2-NgTET1 and application thereof in improving 5caC (cubic-alternating current) ratio in TET enzyme oxidation product | 翌圣生物科技(上海)股份有限公司 | 2023-06-20 | — | — | CN | claimed |
| CN-114591440-B | Recombinant TET enzyme MBD4-NgTET1 and application thereof in improving 5caC (cubic-alternating current) ratio in TET enzyme oxidation product | 翌圣生物科技(上海)股份有限公司 | 2023-06-20 | — | — | CN | claimed |
| CN-114591441-B | Recombinant TET enzyme MBD3-NgTET1 and application thereof in improving 5caC (cubic-alternating current) ratio in TET enzyme oxidation product | 翌圣生物科技(上海)股份有限公司 | 2023-06-20 | — | — | CN | claimed |
| CN-115947646-A | Method for photo-catalytic hydroxylation of aryl or heteroaryl halide | 浙江工业大学 | 2023-04-11 | — | — | CN | claimed |
| WO-2022185599-A1 | CARBONYLATED PROTEIN REDUCING AGENT FOR HAIR | クラシエホームプロダクツ株式会社 | 2022-09-09 | — | — | WO | claimed |
| WO-2015123519-A2 | PROCESSES FOR PREPARING FUSED HETEROCYCLIC ION CHANNEL MODULATORS | GILEAD SCIENCES, INC. (US) | 2015-08-20 | — | — | WO | claimed |
| EP-2906566-A1 | PROCESS FOR MAKING THIENOPYRIMIDINE COMPOUNDS | F. Hoffmann-La Roche AG (CH) | 2015-08-19 | — | — | EP | claimed |
| CN-104844535-A | Method for preparing condensed heterocyclic ion channel conditioning agent | GILEAD SCIENCES INC | 2015-08-19 | — | — | CN | claimed |
| US-20150225384-A1 | PROCESSES FOR PREPARING FUSED HETEROCYCLIC ION CHANNEL MODULATORS | GILEAD SCIENCES, INC. | 2015-08-13 | — | — | US | claimed |
| US-8895729-B2 | Process for making thienopyrimidine compounds | GENENTECH, INC. (US) | 2014-11-25 | — | — | US | claimed |
| US-20140128600-A1 | METHODS FOR PREPARING NAPHTHYRIDINES | BIONOMICS LIMITED (AU) | 2014-05-08 | — | — | US | claimed |
| WO-2014056955-A1 | PROCESS FOR MAKING THIENOPYRIMIDINE COMPOUNDS | F. HOFFMANN-LA ROCHE AG (CH) | 2014-04-17 | — | — | WO | claimed |
| US-20140100366-A1 | PROCESS FOR MAKING THIENOPYRIMIDINE COMPOUNDS | GENENTECH, INC. (US) | 2014-04-10 | — | — | US | claimed |
| EP-2707367-A1 | METHODS FOR PREPARING NAPHTHYRIDINES | Bionomics Limited (AU) | 2014-03-19 | — | — | EP | claimed |
| WO-2012151640-A1 | METHODS FOR PREPARING NAPHTHYRIDINES | BIONOMICS LIMITED (AU) | 2012-11-15 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140128600-A1 | METHODS FOR PREPARING NAPHTHYRIDINES | NQO1, CYP1A1, IPO4 | L3MBTL1 4878/4885KDM4E 3399/4885SMN1; SMN2 3903/4885 |
| US-20240018107-A1 | PROCESS FOR THE MANUFACTURING OF (6AR,10AR)-7-PROPYL-6,6A,7,8,9,10,10A,11-OCTAHYDRO-[1,3]DIOXOLO[4',5':5,6]BENZO[1,2-G]QUINOLINE AND (4AR,10AR)-1-PROPYL-1,2,3,4,4A,5,10,10A-OCTAHYDRO-BENZO[G]QUINOLINE-6,7-DIOL | PARK7, SNCA, CYP1B1 | L3MBTL1 2698/4885KDM4E 1034/4885SMN1; SMN2 330/4885 |
| US-20150225384-A1 | PROCESSES FOR PREPARING FUSED HETEROCYCLIC ION CHANNEL MODULATORS | KCNN2, KCNJ2, KCNN1 | L3MBTL1 4686/4885KDM4E 1924/4885SMN1; SMN2 834/4885 |
| US-20140100366-A1 | PROCESS FOR MAKING THIENOPYRIMIDINE COMPOUNDS | MTOR, PIK3CD, PIK3CA | L3MBTL1 3985/4885KDM4E 1457/4885SMN1; SMN2 1757/4885 |
| US-20230346903-A1 | GROUP B STREPTOCOCCUS POLYSACCHARIDE-PROTEIN CONJUGATES, METHODS FOR PRODUCING CONJUGATES, IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATES, AND USES THEREOF | SIGLEC7, SIGLEC9, FCGR3B | L3MBTL1 3989/4885KDM4E 2366/4885SMN1; SMN2 3027/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.